Molecular Imprints Sales Testament To Systems Capabilities - News Item

Molecular Imprints, Inc. (MII), the leading manufacturer of step and flash (S-FIL) imprint lithography equipment, continues to prove the capabilities of its systems with the latest sales of its Imprio 100 tool to South Korea's new National Nanofab Center at the Korea Institute of Science and Technology, as well as to a global electronics company headquartered in Northern California. The Imprio 100 system represents the next generation in nano-lithography. This tool delivers high resolution, sub-micron alignment, and 3-dimensional replication, to customers seeking cost-effective, sub-100nm lithography. The Imprio 100 can handle up to 200mm wafers, with fine alignment to 250nm, 3 sigma.

"We are very excited that these two leading customers are using our S-FIL technology in their latest research and development," said Dr. Norm Schumaker, CEO of Molecular Imprints. "These purchases provide strong customer validation of our advanced performance and signify a new, long-awaited era in lithography, which has the potential to revolutionize electronic products and applications. In addition to providing the best nano-imprint technology, MII's goal is to now offer process extendibility and support that can enable device features down to 30nm for a variety of applications such as CMOS processing, photonics, bio devices and many others."

Posted 10th February 2004

Tell Us What You Think

Do you have a review, update or anything you would like to add to this article?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.